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uric acid and nonalcoholic fatty liver diseaseTo the Editor:
We read with great interest the article by Shih et al.1 In this
study involving 5370 subjects from a U.S. population, they
found that serum uric acid levels were associated with
nonalcoholic fatty liver disease (NAFLD) in a dose-response
relationship using either the cut-off value of hyperuricemia
or sex-specific quintiles of serum uric acid. Additionally,
this association exists independent of age, sex, race, body
mass index, and other metabolic components. Uric acid
plays a role in several chronic disease states, including
hypertension, diabetes, metabolic syndrome (MS), and
cardiovascular disease, rather than gout or chronic ne-
phropathy.2 Although the current study provided additional
evidence regarding the relationship between uric acid and
NAFLD, several issues deserve further discussion.
First, hyperuricemia is associated with MS, and NAFLD is
considered as the manifestation of MS in the liver.3 In this
study, the association of elevated serum uric acid levels
with NAFLD was found to be independent of MS-related
components. Furthermore, hyperuricemia is associated
with histological liver injury, including steatosis grade and
lobular inflammation in NAFLD patients, suggesting that
hyperuricemia exhibits a synergistic effect with MS on
NAFLD development and severity.4 Second, the cross-
sectional design of the study cannot determine causality
between uric acid and NAFLD. Some cellular studies re-
ported that uric acid increased the accumulation of tri-
glycerides in hepatocytes.5 Additionally, a prospective
large-scaled cohort study showed that serum uric acid
levels were predictive of the development of incident
NAFLD.6 These results indicated that elevated uric acid
levels may exert a causal effect on NAFLD development.
Third, the cut-off value for hyperuricemia was initially
defined according to the incidence of gout attack. This
study showed increasing risk of NAFLD as compared withConflicts of interest: The authors have no conflicts of interest
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levels, which was far below the traditional definition. For
preventing complications from metabolic or cardiovascular
diseases, the normal range of serum uric acid levels should
be revised. Finally, effective medications for hyperurice-
mia are clinically available. The determination of whether
treating hyperuricemia can reduce the risk of NAFLD,
metabolic, or cardiovascular diseases requires confirmation
by further clinical studies.
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